BUSINESS● LOWJul 31 · Jul 31, 2026, 12:45 PM
Sun Pharma misses Q1 estimates as US generics drag offsets India growth
livemint.com · India
Sun Pharma's first-quarter financial results fell short of estimates, primarily due to struggles in the US generics market despite growth in India. This report details the company's recent financial performance and market challenges.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from India
HEALTH35m agoNext-generation antivenom fights India’s deadliest snakesThe TelegraphBUSINESS1h agoApplied Materials to invest $5B in India over the next decadeSeeking Alpha TechPOLITICS1h agoTrump gains a tariff weapon against China and India. Will he use it?CNBCPOLITICS2h agoIndia news: New Delhi vows to ensure 'energy security' amid Trump's 100% tariffs threatDW News [en]
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS9m agoMoeve starts building Europe's largest green hydrogen project in HuelvaEuroNews [en]BUSINESS9m agoHong Kong property market gets reprieve on rates, but position remains precariousSouth China Morning Post